Literature DB >> 2557251

Immunoglobulin and T cell receptor gene rearrangements in lymphoproliferative disorders.

H Daus1, G Schwarze, H Pees, H Radtke, G Kümel, P G Scheurlen.   

Abstract

Thirty-one samples representing Hodgkin's and non-Hodgkin's lymphomas, angioimmunoblastic lymphadenopathy (AILD), and benign follicular hyperplasia in HIV infections were examined for rearrangements of the immunoglobulin (Ig) and T cell receptor (TcR) beta-chain gene loci. In 11 of 12 non-Hodgkin's lymphomas (classified as Burkitt lymphoma (2), centrocytic lymphoma (1), centrocytic-centroblastic lymphoma (5), centroblastic lymphoma (3], only rearranged Ig genes could be detected. The exceptional case was an unclassified high-grade lymphoma, which represented a rearrangement of the TcR beta-chain. We also examined DNA from lymphoid neoplasms in which the lineage of the malignant cell was still controversial. Rearrangement of the TcR could exclusively be demonstrated in all 3 cases of AILD. One Ig gene rearrangement and 4 TcR beta-chain rearrangements were found in 13 samples of Hodgkin's lymphomas (11 lymph nodes, 1 pleura effusion and 1 bone biopsy with proven infiltration). Examination of 3 cases of benign follicular hyperplasia in HIV infection represented one Ig rearrangement.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2557251     DOI: 10.1159/000163523

Source DB:  PubMed          Journal:  Exp Cell Biol        ISSN: 0304-3568


  2 in total

1.  An unusual allelic form of the immunoglobulin lambda constant region genes in the Japanese.

Authors:  P H Kay; J Moriuchi; P J Ma; E Saueracker
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 2.  Novel Approaches in Molecular Characterization of Classical Hodgkin Lymphoma.

Authors:  Diede A G van Bladel; Wendy B C Stevens; Michiel van den Brand; Leonie I Kroeze; Patricia J T A Groenen; J Han J M van Krieken; Konnie M Hebeda; Blanca Scheijen
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.